Inventor · disambiguated record
Monika Ermann
Also filed as: ERMANN MONIKA
18 granted patents·5 pending applications·301 citations·filing 2004–2022
94Inventor score
Files withBOEHRINGER INGELHEIM INT9FACIO INTELLECTUAL PROPERTY B V3BARTOLOZZI ALESSANDRA2BERRY ANGELA2HICKEY EUGENE RICHARD2
Top patents by PatentIndex Score
23 records- 0197US7595397B2Compounds which modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2006·Granted Sep 29, 2009·90 cites·4 claims
- 0295US8048899B2Compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2009·Granted Nov 1, 2011·40 cites·32 claims
- 0393US7935715B2Compounds which modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2007·Granted May 3, 2011·34 cites·3 claims
- 0493US7928123B2Compounds which modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2007·Granted Apr 19, 2011·32 cites·8 claims
- 0592US8362039B2Therapeutic uses of compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2011·Granted Jan 29, 2013·17 cites·20 claims
- 0691US8349871B2Therapeutic uses of compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2011·Granted Jan 8, 2013·15 cites·6 claims
- 0789US8329735B2Tetrazole compounds which selectively modulate the CB2 receptorERMANN MONIKA·Filed 2011·Granted Dec 11, 2012·26 cites·11 claims
- 0888US8299111B2Compounds which modulate the CB2 receptorBERRY ANGELA·Filed 2010·Granted Oct 30, 2012·14 cites·9 claims
- 0986US8372874B2Compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2009·Granted Feb 12, 2013·6 cites·12 claims
- 1081US8829034B2Compounds which modulate the CB2 receptorBERRY ANGELA·Filed 2011·Granted Sep 9, 2014·6 cites·9 claims
- 1180US8735430B2Compounds which selectively modulate the CB2 receptorBARTOLOZZI ALESSANDRA·Filed 2012·Granted May 27, 2014·6 cites·13 claims
- 1277US8957063B2Amine and ether compounds which modulate the CB2 receptorCIRILLO PIER FRANCESCO·Filed 2009·Granted Feb 17, 2015·6 cites·5 claims
- 1377US8846936B2Sulfonyl compounds which modulate the CB2 receptorHICKEY EUGENE RICHARD·Filed 2011·Granted Sep 30, 2014·6 cites·14 claims
- 1473US10973820B2Compounds for treatment of diseases related to DUX4 expressionFACIO INTELLECTUAL PROPERTY B V·Filed 2018·Granted Apr 13, 2021·2 cites·12 claims
- 1571US9868736B2Deubiquitinase inhibitors and methods for use of the sameUNIV MICHIGAN REGENTS·Filed 2014·Granted Jan 16, 2018·1 cites·22 claims
- 1656US2022226318A1Compounds for treatment of diseases related to DUX4 expressionFACIO INTELLECTUAL PROPERTY B V·Filed 2022·Application pending·0 cites
- 1751US2021177847A1Compounds for treatment of diseases related to DUX4 expressionFACIO INTELLECTUAL PROPERTY B V·Filed 2018·Application pending·0 cites
- 1850US2010261708A1Diazepane Compounds Which Modulate The CB2 ReceptorBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 1946US2012015988A1Sulfone Compounds Which Modulate The CB2 ReceptorHICKEY EUGENE RICHARD·Filed 2009·Application pending·0 cites
- 2044US2005070554A1Substituted heterocyclic compounds and methods of useAMGEN INC·Filed 2004·Application pending·0 cites
- 2138US9315454B2Compounds which modulate the CB2 receptorBARTOLOZZI ALESSANDRA·Filed 2011·Granted Apr 19, 2016·0 cites·12 claims
- 2235US10472341B2Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseasesAPEIRON BIOLOGICS AG·Filed 2016·Granted Nov 12, 2019·0 cites·30 claims
- 2335US8383651B2Compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2010·Granted Feb 26, 2013·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →